Combination of Uric Acid and Pro-Inflammatory Cytokines in Discriminating Patients with Gout from Healthy Controls

References

• Dalbeth N, Gosling A, Gaffo A, Abhishek A. Gout. Lancet. 2021;397:1843–1855. doi:10.1016/s0140-6736(21)00569-9
   PubMed Web of Science ®Google Scholar
• Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16:380–390. doi:10.1038/s41584-020-0441-1
   PubMed Web of Science ®Google Scholar
• Kuo C, Grainge M, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2015;74:661–667. doi:10.1136/annrheumdis-2013-204463
   PubMed Web of Science ®Google Scholar
• Nannoni G, Volterrani G, Mattarocci A, Minoretti P, Emanuele E. Comparative efficacy and safety of Verbascox - a proprietary herbal extract capable of inhibiting human cyclooxygenase-2 - and celecoxib for knee osteoarthritis. Drug Discov Ther. 2020;14:129–134. doi:10.5582/ddt.2020.03034
   PubMed Web of Science ®Google Scholar
• Davies J, Riede P, van Langevelde K, Teh J. Recent developments in advanced imaging in gout. Ther Adv Musculoskelet Dis. 2019;11:1759720X19844429. doi:10.1177/1759720x19844429
   PubMed Web of Science ®Google Scholar
• Newberry S, FitzGerald J, Motala A, et al. Diagnosis of Gout: a Systematic Review in Support of an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2017;166:27–36. doi:10.7326/m16-0462
   PubMed Web of Science ®Google Scholar
• Underwood M. Diagnosis and management of gout. BMJ. 2006;332:1315–1319. doi:10.1136/bmj.332.7553.1315
   PubMed Web of Science ®Google Scholar
• Schlesinger N. Diagnosing and treating gout: a review to aid primary care physicians. Postgrad Med. 2010;122:157–161. doi:10.3810/pgm.2010.03.2133
   PubMed Web of Science ®Google Scholar
• Cicero A, Fogacci F, Cincione R, Tocci G, Borghi C. Clinical Effects of Xanthine Oxidase Inhibitors in Hyperuricemic Patients. Med Principles Practice. 2021;30:122–130. doi:10.1159/000512178
   PubMed Web of Science ®Google Scholar
• Cicero A, Fogacci F, Kuwabara M, Borghi C. Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: an Evidence-Based Update. Medicina. 2021;57. doi:10.3390/medicina57010058
   Web of Science ®Google Scholar
• Dalbeth N, Phipps-Green A, Frampton C, Neogi T, Taylor W, Merriman T. Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis. Ann Rheum Dis. 2018;77:1048–1052. doi:10.1136/annrheumdis-2017-212288
   PubMed Web of Science ®Google Scholar
• Lin K, Lin H, Chou P. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol. 2000;27:1501–1505.
   PubMed Web of Science ®Google Scholar
• Richette P, Doherty M, Pascual E, et al. updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis. 2018;2020(79):31–38. doi:10.1136/annrheumdis-2019-215315
   Web of Science ®Google Scholar
• Ragab G, Elshahaly M, Bardin T. Gout: an old disease in new perspective - A review. J Adv Res. 2017;8:495–511. doi:10.1016/j.jare.2017.04.008
   PubMed Web of Science ®Google Scholar
• So A, Martinon F. Inflammation in gout: mechanisms and therapeutic targets. Nat Rev Rheumatol. 2017;13:639–647. doi:10.1038/nrrheum.2017.155
   PubMed Web of Science ®Google Scholar
• Zeng M, Dang W, Chen B, et al. IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response. Clin Rheumatol. 2016;35:2251–2258. doi:10.1007/s10067-015-3109-5
   PubMed Web of Science ®Google Scholar
• Trifirò G, Morabito P, Cavagna L, et al. Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study. Ann Rheum Dis. 2013;72:694–700. doi:10.1136/annrheumdis-2011-201254
   PubMed Web of Science ®Google Scholar
• Luk A, Simkin P. Epidemiology of hyperuricemia and gout. Am j Managed Care. 2005;11:S435–442.
   PubMed Web of Science ®Google Scholar
• Primatesta P, Plana E, Rothenbacher D. Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population. BMC Musculoskelet Disord. 2011;12:103. doi:10.1186/1471-2474-12-103
   PubMed Web of Science ®Google Scholar
• Choi H, Ford E. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med. 2007;120:442–447. doi:10.1016/j.amjmed.2006.06.040
   PubMed Web of Science ®Google Scholar
• Stamp L, Dalbeth N. Screening for hyperuricaemia and gout: a perspective and research agenda. Nature Reviews Rheumatology. 2014;10(12):752–756. doi:10.1038/nrrheum.2014.139
   PubMed Web of Science ®Google Scholar
• Rock K, Kataoka H, Lai J. Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol. 2013;9:13–23. doi:10.1038/nrrheum.2012.143
   PubMed Web of Science ®Google Scholar
• Wallace S, Robinson H, Masi A, Decker J, McCarty D, Yü T. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20:895–900. doi:10.1002/art.1780200320
   PubMed Web of Science ®Google Scholar
• Cabău G, Crișan T, Klück V, Popp R, Joosten L. Urate-induced immune programming: consequences for gouty arthritis and hyperuricemia. Immunol Rev. 2020;294:92–105. doi:10.1111/imr.12833
   PubMed Web of Science ®Google Scholar
• Jiang X, Li M, Yang Q, Du L, Du J, Zhou J. Oxidized low density lipoprotein and inflammation in gout patients. Cell Biochem Biophys. 2014;69:65–69. doi:10.1007/s12013-013-9767-5
   PubMed Web of Science ®Google Scholar
• Higgins P, Dawson J, Walters M. The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular disease. Cardiovasc Psychiatry Neurol. 2009;2009:282059. doi:10.1155/2009/282059
   PubMedGoogle Scholar
• Jin M, Yang F, Yang I, et al. Uric acid, hyperuricemia and vascular diseases. Front Biosci. 2012;17:656–669. doi:10.2741/3950
   PubMed Web of Science ®Google Scholar
• Lu Z, Chen Y, Jing X, Wang N, Zhang T, Hu C. Detection and Identification of Serum Peptides Biomarker in Papillary Thyroid Cancer. Med Sci Monitor. 2018;24:1581–1587. doi:10.12659/msm.907768
   PubMed Web of Science ®Google Scholar
• Enroth S, Berggrund M, Lycke M, et al. High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer. Commun Biol. 2019;2:221. doi:10.1038/s42003-019-0464-9
   PubMed Web of Science ®Google Scholar
• Tang Y. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation–United States, 2010-2012. Morbidity Mortality Weekly Rep. 2013;62:869–873.
   PubMed Web of Science ®Google Scholar
• Lenski M, Scherer M. Analysis of synovial inflammatory markers to differ infectious from gouty arthritis. Clin Biochem. 2014;47:49–55. doi:10.1016/j.clinbiochem.2013.10.019
   PubMed Web of Science ®Google Scholar
• Qing Y, Zheng J, Tang Y, Dai F, Dong Z, Zhang Q. LncRNAs Landscape in the patients of primary gout by microarray analysis. PLoS One. 2021;16:e0232918. doi:10.1371/journal.pone.0232918
   PubMed Web of Science ®Google Scholar
• Ning Y, Yang G, Chen Y, et al. Characteristics of the Urinary Microbiome From Patients With Gout: a Prospective Study. Front Endocrinol (Lausanne). 2020;11:272. doi:10.3389/fendo.2020.00272
   PubMed Web of Science ®Google Scholar
• Guo Z, Zhang J, Wang Z, et al. Intestinal Microbiota Distinguish Gout Patients from Healthy Humans. Sci Rep. 2016;6:20602. doi:10.1038/srep20602
   PubMed Web of Science ®Google Scholar
• Gregolini L, Ferrari S, Marcolongo R, Aleo M, Marinello E, Bianchi E. Hormonal aspects of human gout–excretion of adrenal hormone derivatives in gouty patients. Clin Chim Acta. 1983;130:269–277. doi:10.1016/0009-8981(83)90300-5
   PubMed Web of Science ®Google Scholar
• Fogacci F, Borghi C, Di Micoli A, Degli Esposti D, Cicero A. Inequalities in enrollment of women and racial minorities in trials testing uric acid lowering drugs. Nutrition Metab Cardiovascular Dis. 2021;31:3305–3313. doi:10.1016/j.numecd.2021.09.011
   PubMed Web of Science ®Google Scholar
• Gibson T. Hypertension, its treatment, hyperuricaemia and gout. Curr Opin Rheumatol. 2013;25:217–222. doi:10.1097/BOR.0b013e32835cedd4
   PubMed Web of Science ®Google Scholar